https://dasherneuroscience.com/wp-content/uploads/2026/05/Image_20260529_111447_347.jpeg
1108
1477
cjhuang
/wp-content/uploads/2026/03/LOGO_Primary.png
cjhuang2026-05-29 15:03:482026-05-29 15:04:24Dasher Neuroscience Exhibits at WPC 2026 and Hosts Cocktail Social in PhoenixDasher Neuroscience Press Releases
Breaking News and Milestones
Corporate News
https://dasherneuroscience.com/wp-content/uploads/2026/05/Image_20260529_111447_347.jpeg
1108
1477
cjhuang
/wp-content/uploads/2026/03/LOGO_Primary.png
cjhuang2026-05-29 15:03:482026-05-29 15:04:24Dasher Neuroscience Exhibits at WPC 2026 and Hosts Cocktail Social in Phoenix
https://dasherneuroscience.com/wp-content/uploads/2026/05/B9881426-1446-49AC-B661-473984B6AEE2_1_201_a.jpeg
1108
1477
cjhuang
/wp-content/uploads/2026/03/LOGO_Primary.png
cjhuang2026-05-28 16:56:292026-05-29 09:51:54Shaping the Future of Medicine: Dasher Neuroscience at the Morgan Stanley Asia AI Summit
https://dasherneuroscience.com/wp-content/uploads/2026/03/cropped-favicon.png
512
512
cjhuang
/wp-content/uploads/2026/03/LOGO_Primary.png
cjhuang2026-05-25 15:48:072026-05-25 16:02:24Dasher Neuroscience at WPC 2026Clinical and Research Updates
https://dasherneuroscience.com/wp-content/uploads/2026/03/favicon.png
512
512
tflo
/wp-content/uploads/2026/03/LOGO_Primary.png
tflo2026-04-14 14:52:442026-05-07 10:05:11YODA-KY (7829) YA-101 Granted Orphan Drug Designation by the EU EMA for the Treatment of Multiple System Atrophy
https://dasherneuroscience.com/wp-content/uploads/2026/03/favicon.png
512
512
tflo
/wp-content/uploads/2026/03/LOGO_Primary.png
tflo2026-04-14 14:51:132026-04-14 14:51:13YODA-KY (7829) YA-101 Receives Orphan Drug Designation in Japan, Following U.S. FDA Fast Track, Advancing Global Development Plans
https://dasherneuroscience.com/wp-content/uploads/2026/03/favicon.png
512
512
tflo
/wp-content/uploads/2026/03/LOGO_Primary.png
tflo2026-04-14 14:47:122026-04-14 14:47:12YODA-KY (7829) New Drug YA-101 Granted US FDA “Fast Track Designation” for the Treatment of Multiple System AtrophyNew Collaborations and Agreements
https://dasherneuroscience.com/wp-content/uploads/2026/03/favicon.png
512
512
tflo
/wp-content/uploads/2026/03/LOGO_Primary.png
tflo2026-04-14 14:54:582026-04-16 13:01:04Taiwan’s First: YODA-KY (7829) AI-Developed Drug Prioritized by iLCT for Parkinson’s Disease Development; Signs MOUs with Australia and New Zealand to Expand Clinical Reach
https://dasherneuroscience.com/wp-content/uploads/2026/04/IMG_4346-scaled.jpeg
2560
1920
tflo
/wp-content/uploads/2026/03/LOGO_Primary.png
tflo2026-04-07 16:40:362026-04-16 13:02:59YODA-KY (7829) Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA and Advance AI-Driven Parkinson’s Drug Development in Europe